Montelukast Sodium Market: How Is Pediatric Asthma and Allergic Rhinitis Driving Montelukast Demand?
The Montelukast Sodium Market in 2026 is significantly driven by pediatric respiratory and allergic disease applications, where montelukast's availability in age-appropriate formulations including granule sachets for children aged six months to five years and chewable tablets for children aged two to fourteen years provides an oral administration option for the pediatric asthma and allergic...
0 Comments 0 Shares 27 Views 0 Reviews